NCT00000219CompletedPhase 1
Buprenorphine Dose Alteration Study
Conditions
Drugs
Trial Snapshot
- Phase
- Phase 1
- Status
- Completed
- Sponsor
- University of Vermont
- Locations
- 2
- Primary Endpoint
- Physiological changes in: pupil diameter
Study Overview
Brief Summary
The purpose of this study is to examine the effects in buprenorphine dose alterations in opioid dependent individuals being maintained on buprenorphine.
Study Design
- Study Type
- Interventional
- Primary Purpose
- Treatment
- Masking
- Double
Eligibility Criteria
- Ages
- 19 Years to 41 Years (Adult)
- Sex
- Male
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Please contact site for information.
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Physiological changes in: pupil diameter
Subjective dose estimate
Physiological changes in: blood pressure
Physiological changes in: respiration
Physiological changes in: heart rate
Opioid withdrawal
Drug effect characteristics: ARCI
Physiological changes in: skin temperature
Secondary Outcomes
No secondary outcomes reported
Investigators
Study Sites (2)
Loading locations...
Similar Trials
Completed
Not Applicable
Buprenorphine Dose Adjustments and Gestational AgeNeonatal Abstinence SyndromeNCT03028883St. Louis University40
Completed
Phase 2
Alternate Day Buprenorphine Administration, Phase X - 15Opioid-Related DisordersNCT00000233National Institute on Drug Abuse (NIDA)
Completed
Phase 2
Buprenorphine Maintenance for Opioid Addicts - 2Opioid-Related DisordersNCT00000203Yale University
Completed
Phase 2
Buprenorphine Maintenance for Opiate Dependence - 6Opioid-Related DisordersSubstance-Related DisordersNCT00000357National Institute on Drug Abuse (NIDA)
Completed
Phase 1
Buprenorphine Dose Escalation Trial for Treatment of Non-Dependent Opiate Users - 2Opioid-Related DisordersSubstance-Related DisordersNCT00015041National Institute on Drug Abuse (NIDA)